SYSTEMIC LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEMIC LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEMIC LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lupus drug safety checked over time in 261 patients
Disease control CompletedThis study looked at the long-term safety of an experimental drug called BMS-986165 in 261 adults with systemic lupus erythematosus (SLE). Participants had already completed an earlier lupus study and continued taking the drug. Researchers tracked side effects, serious health eve…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Apr 28, 2026 21:36 UTC
-
New lupus drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested whether nipocalimab, an investigational drug, can help people with active systemic lupus erythematosus (SLE) better than a placebo. About 228 adults with SLE took part. The main goal was to see if more people on nipocalimab achieved a meaningful reduction in lup…
Matched conditions: SYSTEMIC LUPUS ERYTHEMATOSUS
Phase: PHASE2 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC